Thomas Lehman, Pharm D
About Thomas Lehman, Pharm D
Thomas Lehman, Pharm D, is the Senior Director of Global Medical Affairs, Rheumatology at Bristol Myers Squibb, with extensive experience in managing a range of therapeutic areas including immune-mediated diseases, fibrosis, and virology.
Title
Thomas Lehman currently holds the position of Senior Director, Global Medical Affairs, Rheumatology at Bristol Myers Squibb. In addition to this role, he also serves as Co-Director for the Pharmaceutical Industry Fellowship Program, also at Bristol Myers Squibb, in Princeton, New Jersey, United States.
Previous Roles at Bristol Myers Squibb
Before becoming the Senior Director, Global Medical Affairs, Rheumatology, Thomas Lehman served as the Development Lead during a Tour of Duty in 2023. This eight-month assignment was based in Princeton, New Jersey, United States.
Experience at Rutgers University and CVS Caremark Corporation
Thomas Lehman holds valuable academic and professional experience outside of Bristol Myers Squibb. From 2012 to 2014, he was an Adjunct Associate Professor of Pharmacy at Rutgers University. Concurrently, he worked at CVS Caremark Corporation as a Pharmacist. His earlier roles at CVS included serving as a Pharmacy Technician/Intern from 2004 to 2012.
Educational Background
Thomas Lehman studied at the University of the Sciences in Philadelphia, where he completed his Doctor of Pharmacy degree. He also pursued a Postdoctoral Fellowship at Rutgers University, specializing in the Rutgers Pharmaceutical Industry Fellowship program.
Achievements and Expertise in Medical Affairs
Thomas Lehman has an established track record in medical affairs, particularly in the field of rheumatology. Notably, he led the first-in-class launch of SOTYKTU (deucravacitinib) for Psoriasis. His therapeutic expertise spans immune-mediated diseases, fibrosis, and virology. He has experience managing blockbuster and niche products across their entire lifecycle, from pre-launch to maturity. His work has included contributions to the medical affairs for ORENCIA (abatacept) and involvement in therapeutic areas like Rheumatology, Transplant, and Virology, with specific focus on diseases such as Lupus, Rheumatoid Arthritis, and HIV.